Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia

Pain Medicine

Volumn 10, Issue 5, 2009, Pages 902-909

  Kanai, Akifumi ^a   Kumaki, Chie ^a   Niki, Yuriko ^a   Suzuki, Asaha ^a   Tazawa, Toshiharu ^a   Okamoto, Hirotsugu ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Lidocaine; Post herpetic neuralgia; Topical spray

Indexed keywords

LIDOCAINE; PLACEBO;

ADULT; AGED; ALLODYNIA; ANALGESIA; APPLICATION SITE IRRITATION; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INTOXICATION; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; OPEN STUDY; PAIN ASSESSMENT; PARESTHESIA; PATIENT SATISFACTION; POSTHERPETIC NEURALGIA; PULSE RATE; PUMP; RANDOMIZED CONTROLLED TRIAL; SENSORY DYSFUNCTION; SIDE EFFECT; VISUAL ANALOG SCALE; WEAKNESS;

ADMINISTRATION, TOPICAL; ADULT; AEROSOLS; AGED; AGED, 80 AND OVER; ANESTHETICS, LOCAL; CROSS-OVER STUDIES; DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; PAIN MEASUREMENT;

EID: 68349144569     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2009.00662.x     Document Type: Article

References (19)

1. Gazewood JD, Meadows S, Halverson L. Clinical inquiries. What is the prognosis of postherpetic neuralgia? J Fam Pract 2003;52:496-7.
2. Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: A quantitative systematic review. PLoS Med 2005;2:628-44.
3. Stow PJ, Glynn CJ, Minor B. EMLA cream in the treatment of post-herpetic neuralgia. Efficacy and pharmacokinetic profile. Pain 1989;39:301-5.
4. Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 1995;37:246-53.
5. Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: Double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44.
6. Wallace MS. Calcium and sodium channel antagonists for the treatment of pain. Clin J Pain 2000;16:S80-5.
7. Sinclair R, Cassuto J, Högström S, et al. Topical anesthesia with lidocaine aerosol in the control of postoperative pain. Anesthesiology 1988;68:895-901.
8. Sinclair R, Westlander G, Cassuto J, Hedner T. Postoperative pain relief by topical lidocaine in the surgical wound of hysterectomized patients. Acta Anaesthesiol Scand 1996;40:589-94.
9. Katz NP, Gammaitoni AR, Davis MW, Dworkin RH. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: An effectiveness trial. Pain Med 2002;3:324-32.
10. Tremont-Lukats IW, Challapalli V, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetics to relieve neuropathic pain: A systematic review and meta-analysis. Anesth Analg 2005;101:1738-49.
11. Wallace MS, Dyck JB, Rossi SS, Yaksh TL. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain 1996;66:69-77.
12. Gammaitoni AR, Alvarez NA, Galer BS. Pharmacokinetics and safety of continuously applied lidocaine patches 5 %. Am J Health Syst Pharm 2002;59:2215-20.
13. Johnson ME, Mitragotri S, Patel A, Blankschtein D, Langer R. Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery. J Pharm Sci 1996;85:670-9.
14. Padula C, Colombo G, Nicoli S, et al. Bioadhesive film for the transdermal delivery of lidocaine: In vitro and in vivo behavior. J Control Release 2003;88:277-85.
15. Riviere JE, Papich MG. Potential and problems of developing transdermal patches for veterinary applications. Adv Drug Deliv Rev 2001;50:175-203.
16. Pettifer GR, Hosgood G. The effect of inhalant anesthetic and body temperature on peri-anesthetic serum concentrations of transdermally administered fentanyl in dogs. Anesth Analg 2004;31:109-20.
17. Rowbotham MC, Fields HL. Post-herpetic neuralgia: The relation of pain complaint, sensory disturbance, and skin temperature. Pain 1989;39:129-44.
18. Kanikkannan N, Singh M. Skin permeation enhancement effect and skin irritation of fatty alcohols. Int J Pharm 2002;248:219-28.
19. Kanai A, Osawa S, Suzuki A, Ishimaru R, Hoka S. Effectiveness of prostaglandin E1 for the treatment of patients with neuropathic pain following herpes zoster. Pain Med 2007;8:36-40.